The Hospital Universitario de Getafe is a public hospital located in Getafe, a city in the Community of Madrid, Spain. It is affiliated with the SERVICIO MADRILEÑO DE SALUD (Madrid Health Service), which is responsible for the administration and management of public healthcare in the region.
The hospital plays a crucial role in providing healthcare services to the local population, offering a range of medical specialties and facilities to meet the diverse healthcare needs of the community. It is equipped with 400 beds, providing general hospitalisation services to approximately 120,000 patients annually. The Surgical Services department performs around 13,000 procedures each year. The hospital also offers External Consultations, handling approximately 350,000 visits per year and the Emergency department attends to around 110,000 visits annually.
Currently, we attend to over 4000 patients in the pharmaceutical care consults of our hospital. Approximately 45% of these patients receive subcutaneous medications associated with 12 different disease programs, including arthritis, psoriasis, inflammatory bowel disease, migraines, multiple sclerosis, asthma, growth deficiency, familial hypercholesterolemia, and more. We have experienced a yearly growth rate of 10% in this regard. However, this challenge extends beyond the hospital, impacting a larger population of patients facing similar difficulties in other healthcare facilities.
The challenge is to improve patient education and training for self-administering subcutaneous medication at home. Biologic medications offer a range of treatments for diseases like arthritis, psoriasis, and multiple sclerosis, requiring long-term self-administration. In Spain, these medications are dispensed from hospital pharmacies for home use, and training is provided by nurses and pharmacists using traditional methods, such as verbal instructions and demonstrations.
However, patients often feel overwhelmed by medical information and emotional stress during hospital visits, making it hard to retain critical details. This can lead to uncertainty when self-administering medication at home.
The solution is a gamified, interactive digital environment to train patients at home. This platform simulates real-life scenarios to help patients practice medication techniques, understand their disease, and retain important information. It also allows interaction with healthcare professionals and peers, fostering empowerment and trust in managing their own healthcare.
MetamedicsVR is committed to developing innovative solutions for the medical sector using technologies such as XR, AI, and web platforms.
MetaMedicsVR (MMVR) is a pioneering medtech/edtech startup based in Spain, revolutionizing the medical sector with cutting-edge technologies like Extended Reality (XR), Artificial Intelligence (AI), and web platforms. MMVR addresses critical challenges in healthcare and education with a focus on patient-centric design and user experience.
MMVR develops immersive and interactive solutions that engage and empower users. From virtual reality applications for medical training to web-based platforms for patients, MMVR delivers accessible and effective innovations, making a global impact.
MetaMedicsVR (MMVR) develops a groundbreaking web-based application to help children manage their subcutaneous treatment medication at home. This solution provides pediatric patients with an experience tailored to their age and emotional needs.
Through engaging activities and interactive features, children actively participate in their treatment journey, improving adherence to medication schedules and understanding their condition. The immersive application supports children by reducing anxiety and promoting a sense of control over their health.
MMVR’s solution also benefits healthcare professionals by automating routine administrative tasks, giving clinicians more time to focus on critical clinical activities and enhancing the quality of care for pediatric patients.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under the Grant Agreement 101071212.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
visibility_offDisable flashes
titleMark headings
settingsBackground Color
zoom_outZoom out
zoom_inZoom in
remove_circle_outlineDecrease font
add_circle_outlineIncrease font
spellcheckReadable font
brightness_highBright contrast
brightness_lowDark contrast
format_underlinedUnderline links
font_downloadMark links